All Stories

MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data

MacroGenics has made the final decision to abandon work on one of its most advanced antibody-drug conjugates (ADCs) after taking a look at the latest phase 2 data.

Mar 21, 2025 - 12:21
 0
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
MacroGenics has made the final decision to abandon work on one of its most advanced antibody-drug conjugates (ADCs) after taking a look at the latest phase 2 data.
Read More

Tags:

Previous Article

Mint House Expands Midwest Footprint with the Grand Opening of The Dylin in Madi...

Next Article

Crescent Hotels & Resorts Announces Management of NoMo SoHo

Related Posts

Globus Medical to buy neurostim developer Nevro for $250M

Globus Medical to buy neurostim developer Nevro for $250M

Feb 10, 2025  0

Flatiron Health irons out pact to bring data capture tech to National Cancer Institute trial sites

Flatiron Health irons out pact to bring data capture te...

Mar 19, 2025  0

Aardvark heads to Nasdaq with $94M IPO to fund more appetite-suppressant trials

Aardvark heads to Nasdaq with $94M IPO to fund more app...

Feb 13, 2025  0